Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Biological in-vivo measurement of dose distribution in patients' lymphocytes by gamma-H2AX immunofluorescence staining: 3D conformal- vs. step-and-shoot IMRT of the prostate gland.

Zwicker F, Swartman B, Sterzing F, Major G, Weber KJ, Huber PE, Thieke C, Debus J, Herfarth K.

Radiat Oncol. 2011 Jun 7;6:62. doi: 10.1186/1748-717X-6-62.

2.

In vivo measurement of dose distribution in patients' lymphocytes: helical tomotherapy versus step-and-shoot IMRT in prostate cancer.

Zwicker F, Swartman B, Roeder F, Sterzing F, Hauswald H, Thieke C, Weber KJ, Huber PE, Schubert K, Debus J, Herfarth K.

J Radiat Res. 2015 Mar;56(2):239-47. doi: 10.1093/jrr/rru096. Epub 2014 Oct 31.

3.

gamma-H2AX foci formation in peripheral blood lymphocytes of tumor patients after local radiotherapy to different sites of the body: dependence on the dose-distribution, irradiated site and time from start of treatment.

Sak A, Grehl S, Erichsen P, Engelhard M, Grannass A, Levegrün S, Pöttgen C, Groneberg M, Stuschke M.

Int J Radiat Biol. 2007 Oct;83(10):639-52.

PMID:
17729159
4.

Biodosimetry Based on γ-H2AX Quantification and Cytogenetics after Partial- and Total-Body Irradiation during Fractionated Radiotherapy.

Zahnreich S, Ebersberger A, Kaina B, Schmidberger H.

Radiat Res. 2015 Apr;183(4):432-46. doi: 10.1667/RR13911.1. Epub 2015 Apr 6.

PMID:
25844946
5.

DNA double-strand breaks and their repair in blood lymphocytes of patients undergoing angiographic procedures.

Kuefner MA, Grudzenski S, Schwab SA, Wiederseiner M, Heckmann M, Bautz W, Lobrich M, Uder M.

Invest Radiol. 2009 Aug;44(8):440-6. doi: 10.1097/RLI.0b013e3181a654a5.

PMID:
19448553
6.

Inverse and forward optimization of one- and two-dimensional intensity-modulated radiation therapy-based treatment of concave-shaped planning target volumes: the case of prostate cancer.

Corletto D, Iori M, Paiusco M, Brait L, Broggi S, Ceresoli G, Iotti C, Calandrino R, Fiorino C.

Radiother Oncol. 2003 Feb;66(2):185-95.

PMID:
12648791
7.

Distinct effects of rectum delineation methods in 3D-conformal vs. IMRT treatment planning of prostate cancer.

Guckenberger M, Meyer J, Baier K, Vordermark D, Flentje M.

Radiat Oncol. 2006 Sep 6;1:34.

8.

Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.

Luxton G, Hancock SL, Boyer AL.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):267-84.

PMID:
15093924
9.

In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer.

Lassmann M, Hänscheid H, Gassen D, Biko J, Meineke V, Reiners C, Scherthan H.

J Nucl Med. 2010 Aug;51(8):1318-25. doi: 10.2967/jnumed.109.071357. Epub 2010 Jul 21.

10.

Gamma-H2AX-based dose estimation for whole and partial body radiation exposure.

Horn S, Barnard S, Rothkamm K.

PLoS One. 2011;6(9):e25113. doi: 10.1371/journal.pone.0025113. Epub 2011 Sep 23.

11.

Role of IMRT in reducing penile doses in dose escalation for prostate cancer.

Sethi A, Mohideen N, Leybovich L, Mulhall J.

Int J Radiat Oncol Biol Phys. 2003 Mar 15;55(4):970-8.

PMID:
12605975
12.

Quantification of gamma-H2AX foci in human lymphocytes: a method for biological dosimetry after ionizing radiation exposure.

Roch-Lefèvre S, Mandina T, Voisin P, Gaëtan G, Mesa JE, Valente M, Bonnesoeur P, García O, Voisin P, Roy L.

Radiat Res. 2010 Aug;174(2):185-94. doi: 10.1667/RR1775.1.

PMID:
20681785
13.

Quantification of Radiation Biomarkers in Leukocytes of Breast Cancer Patients Treated with Different Modalities of 3D-CRT or IMRT.

Zahnreich S, Ebersberger A, Karle H, Kaina B, Schmidberger H.

Radiat Res. 2016 Nov;186(5):508-519. Epub 2016 Oct 27.

PMID:
27788031
14.

Dosimetric analysis and comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy for patients with hepatocellular carcinoma and radiation-induced liver disease.

Cheng JC, Wu JK, Huang CM, Liu HS, Huang DY, Tsai SY, Cheng SH, Jian JJ, Huang AT.

Int J Radiat Oncol Biol Phys. 2003 May 1;56(1):229-34.

PMID:
12694843
15.

EPI-CT: in vitro assessment of the applicability of the γ-H2AX-foci assay as cellular biomarker for exposure in a multicentre study of children in diagnostic radiology.

Vandevoorde C, Gomolka M, Roessler U, Samaga D, Lindholm C, Fernet M, Hall J, Pernot E, El-Saghire H, Baatout S, Kesminiene A, Thierens H.

Int J Radiat Biol. 2015 Aug;91(8):653-63. doi: 10.3109/09553002.2015.1047987. Epub 2015 Jul 8.

PMID:
25968559
16.

Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

PMID:
15913914
17.

Long-term in vivo effects of cisplatin on gamma-H2AX foci signaling in peripheral lymphocytes of tumor patients after irradiation.

Sak A, Grehl S, Engelhard M, Wierlemann A, Kaelberlah HP, Erichsen P, Pöttgen C, Groneberg M, Stuschke M.

Clin Cancer Res. 2009 Apr 15;15(8):2927-34. doi: 10.1158/1078-0432.CCR-08-0650. Epub 2009 Mar 31.

18.

Calibration of the γ-H2AX DNA double strand break focus assay for internal radiation exposure of blood lymphocytes.

Eberlein U, Peper M, Fernández M, Lassmann M, Scherthan H.

PLoS One. 2015 Apr 8;10(4):e0123174. doi: 10.1371/journal.pone.0123174. eCollection 2015.

19.

Reduced activity of double-strand break repair genes in prostate cancer patients with late normal tissue radiation toxicity.

van Oorschot B, Hovingh SE, Moerland PD, Medema JP, Stalpers LJ, Vrieling H, Franken NA.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):664-70. doi: 10.1016/j.ijrobp.2013.11.219. Epub 2014 Jan 8.

PMID:
24411188
20.

Manual versus automated γ-H2AX foci analysis across five European laboratories: can this assay be used for rapid biodosimetry in a large scale radiation accident?

Rothkamm K, Barnard S, Ainsbury EA, Al-Hafidh J, Barquinero JF, Lindholm C, Moquet J, Perälä M, Roch-Lefèvre S, Scherthan H, Thierens H, Vral A, Vandersickel V.

Mutat Res. 2013 Aug 30;756(1-2):170-3. doi: 10.1016/j.mrgentox.2013.04.012. Epub 2013 May 3.

PMID:
23648320

Supplemental Content

Support Center